Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details)

Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2015	Mar. 31, 2015	Sep. 30, 2014	Mar. 31, 2014	Sep. 30, 2015	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free Interest Rate					1.02%	0.71%
Expected life (in years)					3 years 6 months	3 years 6 months
Expected volatility					54.47%	47.94%
Dividend Yield					0.00%	0.00%
Stock-based Compensation Expense	$ 463		$ 406		$ 1,517	$ 1,764
Management [Member] \| Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued		444,364
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 1.73
Chief Executive Officer [Member] \| Performance base shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures				188,165
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				$ 5.10
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value				$ 1.87
Expected life (in years)				5 years
Performance Shares Target Premium				50.00%
Consecutive trading days				60 days
Performance Shares First Tranche [Domain] \| Chief Executive Officer [Member] \| Performance base shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares available for exercise				36,496
Average stock price, performance shares				$ 7.65
Performance Shares Second Tranche [Domain] \| Chief Executive Officer [Member] \| Performance base shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life (in years)				5 years
Performance shares available for exercise				64,460
Average stock price, performance shares				$ 10.20
Performance Shares Final Tranche [Domain] \| Chief Executive Officer [Member] \| Performance base shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life (in years)				5 years
Performance shares available for exercise				87,209
Average stock price, performance shares				$ 15.30